Epoqe Pharma ApS: Financial statements 2023
CVR: 42443670
Source: annual report 2023, Danish Business Authority
01/07/2022 – 30/06/2023
Epoqe Pharma ApS (CVR 42443670) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -19,351 and a net result of DKK -15,427 compared with DKK -18,026 the year before. Equity in the 2023 report amounted to DKK 117,652. The solvency ratio was 4.6%.
- Gross Profit
- DKK -19,351
- Profit/Loss
- DKK -15,427
- Equity
- DKK 117,652
- Total Assets
- DKK 2,579,564
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -19 t. | -15 t. | 118 t. | - |
| 2022 | - | -17 t. | -18 t. | 133 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of October 12, 2023, Anders Gaarsdal Holst has joined the board of directors of Epoqe Pharma ApS.
As of October 12, 2023, Jan Bjerrum Bach has joined the board of directors of Epoqe Pharma ApS.
As of October 12, 2023, Alejandra Maria Cristina Bonifacini Mørk has joined the board of directors of Epoqe Pharma ApS.
About Epoqe Pharma ApS
Epoqe Pharma ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2021. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Patentselskabet af 31. maj 2021 ApS.. The management consists of Mark Stephen Sumeray. The board consists of Anders Gaarsdal Holst (chair), Henrijette Elsebeth Richter, Lars Gredsted and Mark Stephen Sumeray. The company's owners include LUNDBECKFOND INVEST A/S, Helms & Sams ApS and CMCGreenhouse ApS. The company has 5 employees (2026). In 2025, the company reported a gross profit of DKK -13,719,778 and a net result of DKK -13,943,884 compared with DKK -135,919 the year before. Equity in the 2025 report amounted to DKK 30,042,156.